FDA approves new genetic disorder drug
The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of non-cancerous tumors on ...
UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLIâ„¢ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
Newsable Asianet News on MSN2h
Here’s Why Shuttle Pharma is the Most Undervalued Biotech Stock in Our Coverage Universe
Valuation discrepancies in the biotech sector highlight Shuttle Pharma’s incredible potential. With several peer companies in ...
What's on Netflix22h
Welcome to What's on Netflix
Our picks of the movies you need to be watching on Netflix in February.